Equities

Benchmark Holdings PLC

Benchmark Holdings PLC

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (GBX)34.00
  • Today's Change-4.00 / -10.53%
  • Shares traded179.05k
  • 1 Year change-34.93%
  • Beta0.8992
Data delayed at least 20 minutes, as of Mar 29 2023 16:35 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Benchmark Holdings plc is an aquaculture biotechnology company. The Company is focused on delivering products and solutions across genetics, advanced nutrition and health. The Company’s segments include Genetics, Advanced Nutrition and Health. The Genetics segment is salmon breeding technology combined with production facilities to provide a range of genetic merit ova. Advanced Nutrition segment manufactures and provides nutrition and health products to the global aquaculture industry. The Health segment is focused on providing health products to the global aquaculture market. The Company has a portfolio of products and solutions, including salmon eggs with specialist genetic traits, shrimp broodstock, tilapia fry, technology enhanced live feed (Artemia), specialist diets, probiotics and sea lice treatments.

  • Revenue in GBP (TTM)172.76m
  • Net income in GBP-28.01m
  • Incorporated2000
  • Employees847.00
  • Location
    Benchmark Holdings PLCBenchmark House, 8 Smithy Wood DriveSHEFFIELD S35 1QNUnited KingdomGBR
  • Phone+44 114 240 9939
  • Websitehttp://www.benchmarkplc.com/
More ▼

Mergers & acquisitions

Acquired companyDeal statusDateDate /
Deal status
BMK:LSE since
announced
Transaction
value
Benchmark Genetics Iceland hfDeal completed17 Feb 202317 Feb 2023Deal completed-9.81%--
Data delayed at least 20 minutes, as of Mar 29 2023 16:35 BST.

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
AKVA Group ASA259.72m-10.26m179.55m1.47k--1.9952.100.6913-3.61-3.6191.2931.450.94521.725.392,264,890.00-3.730.5127-5.800.77217.1039.09-3.950.50670.7813-0.48280.5252246.506.719.88-1,243.33--9.97--
Atria Oyj1.49bn-4.66m188.60m3.70k--0.70652.150.1265-0.1867-0.186760.0115.941.7011.3014.01---0.37981.07-0.5241.539.9410.84-0.2240.65830.6075--0.3639119.2310.163.3923.19--18.926.96
Salmon Evolution ASA3.61m-2.56m209.87m2.00--1.72--58.19-0.0994-0.09940.14214.520.0230.01660.4689---1.63---1.81--98.64---70.98--1.83--0.2711--282.73---23.76------
Ice Fish Farm AS48.10m-3.18m216.21m51.00--1.2052.804.49-0.4972-0.49727.6725.220.22651.8412.48---1.430.3853-1.650.462335.7735.24-6.321.540.7623-2.910.3325--90.5441.87-303.73--47.42--
Arctic Fish Holding AS45.64m4.79m232.39m71.0048.522.8725.675.091.921.9218.3732.530.33270.2936.948,217,550.003.491.714.032.1867.3849.9910.505.220.62814.270.4444---2.0953.71-59.83--25.33--
Scandi Standard AB (publ)948.52m10.41m253.85m3.14k24.121.385.690.26762.042.04185.5335.701.808.9812.72--2.042.843.044.0636.4939.051.131.740.62983.650.461833.0119.9811.2826.92-4.707.95-8.57
Benchmark Holdings PLC172.76m-28.01m280.93m847.00--0.919219.691.63-0.0398-0.03980.24490.41340.35243.433.66203,964.60-5.31-4.85-6.16-5.5450.8552.92-15.06-19.151.75-0.43430.248--26.562.46-148.91---20.72--
Masoval AS154.62m46.21m299.94m221.006.831.935.161.944.594.5916.6316.180.50490.99545.128,944,249.0015.38--19.00--58.24--30.46--1.077.110.5253--23.09--38.96------
Icelandic Salmon AS111.97m17.88m341.81m174.0019.113.0014.473.057.397.3947.8847.070.72761.9422.4010,603,630.0011.62-2.3213.01-3.1650.3043.6815.97-4.444.5421.870.2661--46.8427.80221.26--4.61--
Froy ASA165.45m17.50m410.66m814.0023.461.598.472.482.592.5924.5138.160.269738.338.83--2.85--3.17--76.00--10.57--0.87355.620.5766--24.73---21.14------
Data as of Mar 29 2023. Currency figures normalised to Benchmark Holdings PLC's reporting currency: UK Pound GBX

Institutional shareholders

66.82%Per cent of shares held by top holders
HolderShares% Held
Ferd Invest ASas of 15 Dec 2022191.92m25.96%
JNE Partners LLPas of 15 Mar 2023168.10m22.74%
Lansdowne Partners (UK) LLPas of 01 Dec 202133.59m4.55%
Harwood Capital LLPas of 31 Mar 202228.71m3.89%
Canaccord Genuity Wealth Ltd.as of 01 Nov 202220.00m2.71%
DNB Asset Management ASas of 31 Jan 202319.83m2.68%
Gresham House Asset Management Ltd. (Investment Management)as of 30 Jun 202214.60m1.98%
Janus Henderson Investors UK Ltd.as of 01 Nov 20228.72m1.18%
United Nations Joint Staff Pension Fundas of 01 Nov 20225.40m0.73%
Baillie Gifford & Co.as of 28 Feb 20233.06m0.41%
More ▼
Data from 31 Mar 2022 - 02 Mar 2023Source: FactSet Research Systems Inc.
An LSEG Business
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.